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BACKGROUND One key element of lung-protective ventila-
tion is the use of a low tidal volume (VT). A sex difference in
use of low tidal volume ventilation (LTVV) has been described
in critically ill ICU patients.
OBJECTIVES The aim of this study was to determine
whether a sex difference in use of LTVV also exists in
operating room patients, and if present what factors drive
this difference.
DESIGN, PATIENTS AND SETTING This is a posthoc
analysis of LAS VEGAS, a 1-week worldwide observational
study in adults requiring intra-operative ventilation during
general anaesthesia for surgery in 146 hospitals in 29
countries.
MAIN OUTCOME MEASURES Women and men were com-
pared with respect to use of LTVV, defined as VT of 8 ml kg
1
or less predicted bodyweight (PBW). A VT was deemed
‘default’ if the set VT was a round number. A mediation analysis
assessedwhich factors may explain the sexdifference in use of
LTVV during intra-operative ventilation.ight © European Society of Anaesthesiology. U
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RESULTS This analysis includes 9864 patients, of whom 5425
(55%) were women. A default VT was often set, both in women
and men; mode VT was 500 ml. Median [IQR] VT was higher in
women than in men (8.6 [7.7 to 9.6] vs. 7.6 [6.8 to 8.4] ml kg1
PBW, P<0.001). Compared with men, women were twice as
likely not to receive LTVV [68.8 vs. 36.0%; relative risk ratio 2.1
(95% CI 1.9 to 2.1), P<0.001]. In the mediation analysis,
patients’ height and actual body weight (ABW) explained 81
and 18% of the sex difference in use of LTVV, respectively; it
was not explained by the use of a default VT.
CONCLUSION In this worldwide cohort of patients receiving
intra-operative ventilation during general anaesthesia for sur-
gery, women received a higher VT than men during intra-
operative ventilation. The risk for a female not to receive LTVV
during surgery was double that of males. Height and ABW
were the two mediators of the sex difference in use of LTVV.
TRIAL REGISTRATION The study was registered at Clin-
icaltrials.gov, NCT01601223
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One key element of lung-protective ventilation is the use
of a low tidal volume (VT).
1,2 Increasing and convincing
evidence for benefit of low tidal volume ventilation
(LTVV) in ICU patients3 stimulated the use of a low
VT in the operating room.
4 Recent studies confirmed that
intra-operative use of lung-protective ventilation, in part
consisting of use of a low VT, protects against postopera-
tive pulmonary complications (PPCs).2,5–7 Despite
recommendations on use of a VT of 8 ml kg
1 predicted
body weight (PBW) or lower,8 LTVV remains grossly
underused. Large observational studies show that more
than a third of surgery patients receive ventilation with a
VT more than 8 ml kg
1 PBW,9 and one in five patients
with a VT more than 10 ml kg
1 PBW.10,11
A recent secondary analysis of the ‘Large observational
study to Understand the Global Impact of Severe Acute
respiratory FailurE’ (LUNG SAFE) showed that female
patients with acute respiratory distress syndrome (ARDS)
received LTVV less often than males.12 It is uncertain
whether a sex difference in use of LTVV also exists in the
operating room. We reassessed the database of the ‘Local
Assessment of VEntilatory management during General
Anaesthesia for Surgery’ (LAS VEGAS) study to describe
and compare the use of LTVV in female versus male
surgery patients. In addition, we ascertained which fac-
tors are associated with this sex difference in use of
LTVV. We hypothesised that women receive intra-oper-
ative LTVV less often than men, and that this difference
is driven by anthropometric factors such as height and
weight, and the use of a possibly sex-specific default VT.
Materials and methods
This is a posthoc analysis of the LAS VEGAS study,9
carried out in accordance with the recommendations of
the ‘STrengthening the Reporting of OBservational stud-
ies in Epidemiology’ (STROBE) statement (checklist
can be found at page 3 of Online Supplement, http://
links.lww.com/EJA/A517) (http://www.strobe-statemen-
t.org/). LAS VEGAS was a worldwide, international,
multicentre, prospective 1-week observational study
describing in detail intra-operative ventilation practices
in the operating rooms of 146 centres in 29 countries.9
Surgical patients were enrolled between 14 January and 4
March 2013. National coordinators selected the exact
period during which data were collected for the study
in their respective country.
The study protocol of the LAS VEGAS study was first
approved on 22 August 2012 by the ethics committee of
the Academic Medical Center, Amsterdam, The
Netherlands (W12_190#12.17.0227, chairperson Prof.
M.P.M. Burger). In all participating centres, approval
was obtained from the institutional review board if
needed, and depending on national or regional legisla-
tion, written informed consent was obtained from the
individual patients.ight © European Society of Anaesthesiology. Un
Eur J Anaesthesiol 2021; 38:1–8OF
The LAS VEGAS study was registered at clinicaltrial.gov
(study identifier NCT01601223).
The LAS VEGAS study enrolled consecutive patients
requiring invasive ventilation during general anaesthesia
for surgery during a predefined calendar week. Exclusion
criteria of the LAS VEGAS study were age less than 18
years, scheduled for pregnancy-related surgery and sur-
gical procedures outside an operating room. The current
posthoc analysis also excluded patients undergoing a
surgical procedure involving cardiopulmonary bypass,
thoracic surgery or planned use of one-lung ventilation
during surgery.
Collected data included baseline characteristics and
demographics, details of the surgical procedure, the
‘Assess Respiratory Risk in Surgical Patients in Catalonia
for postoperative pulmonary complications’ (ARISCAT)
score,13 hourly collection of vital parameters and ventila-
tion data, including VT, positive end-expiratory pressure
(PEEP) and peak pressure (Ppeak), fraction of inspired
oxygen (FIO2) and respiratory rate.
VT was normalised for actual body weight (ABW) and for
PBW, as follows:
VT ;ABW ¼ absolute VT=ABW in kg ðEq: 1Þ (1)
VT ;PBW ¼ absolute VT=PBW in kg ðEq: 2Þ (2)
PBW for women and men was calculated as follows:
men; PBW ¼ 50:0þ 0:91  ðheight in cm
 152:4Þ ðEq:3aÞ (3a)
women; PBW ¼ 45:5þ 0:91  ðheight in cm
 152:4Þ ðEq: 3bÞ (3b)
The primary outcome was use of LTVV, defined as
having received a median VT,PBW of 8 ml kg
1 or less
during intra-operative ventilation. A patient was defined
as possibly having received ventilation with a default VT
when the reported absolute VT was a rounded number, for
example a VT of 200, 250, 300, 350, 400, 450, 500, 550, 600
or 650 ml.
Statistical analysis
A detailed description of the statistical analysis can be
found in the eMethods in the Online Supplement, http://
links.lww.com/EJA/A517. Descriptive statistics were
reported for the study population stratified according
to sex, and as number and relative proportions forauthorized reproduction of this article is prohibited.
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categorical variables and median [IQR] for continuous
variables. No assumptions were made for missing data.
The anthropometric indices were compared between the
sex groups using Wilcoxon rank sum test for continuous
variables. For all analyses, the male sex was used as
reference. The number and proportion of patients receiv-
ing LTVV was described and an unadjusted mixed-effect
generalised linear model considering the centres as ran-
dom effect was used to extract the risk difference. The
proportion of patients receiving LTVV was also assessed
according to quintiles of height and weight. In addition,
the proportions of patients receiving a VT,PBW more than
9 ml kg1 and VT,PBW more than 10 ml kg
1 were
described using a x2 statistic. In all models, continuous
variables were standardised to improve convergence.
Finally, to investigate whether the difference in the use
of LTVV between female and male patients is due to
differences in height, ABW or setting a ‘default’ possibly
sex-dependent VT, a mixed-effect multivariable media-
tion model was used. Mediators are variables that are
affected by group assignment and that subsequently can
affect the outcome. Therefore, mediators are on the
causal pathway of the relationship between group and
outcome, at least partly explaining the effects of the
group on the outcome. In a first step, we assessed the
individual impact of height, weight or use of a fixed VT as
potential mediators for the different use of low VT
according to sex in a multivariable model adjusted by
all the covariates described above. For this model, quasi-
Bayesian confidence intervals were estimated after 10 000
simulations. In a second step, height, weight and setting a
default VT were included at the same time in the same
model to assess the impact and importance of each. In
this second model, the confidence intervals were esti-
mated with bootstrapping with 1000 samples. For the
mediation models, the following estimates are described:
the total effect (estimates the total effect of sex on
ventilation), the average causal mediation effect (ACME,
explains how much of the effect of sex on ventilation is
explained by the mediator [height, weight or setting a
default VT]), the average direct effect (ADE, explains
how much of the effect of sex on ventilation is still
explained by sex after considering the effect of the
mediator) and the proportion of mediation (estimates
the proportion of the total effect that is explained by
the mediator).
All analyses were conducted in R v.3.60 and a P value less
than 0.05 was considered statistically significant.
Results
This analysis included 5425 (55%) women and 4439
(45%) men undergoing intra-operative ventilation not
meeting the additional exclusion criteria. Patient char-
acteristics and anthropometric indices are summarised in
Table 1. Women were median 11 (95% CI 11 to 12) cm
shorter (P< 0.001) and 12 (11 to 13) kg lighter than menyright © European Society of Anaesthesiology. UOF
(P< 0.001). Anaesthesia, surgery and intra-operative ven-
tilation characteristics are shown in Supplementary
eTables 1 and 2, http://links.lww.com/EJA/A517.
VT in women and men are shown in Fig. 1 and Supple-
mentary eFigs. 1, 2 and 3, http://links.lww.com/EJA/
A517. Mean VT was 500 ml, and was similar for women
and men. In women, median VT, ABW and median VT,PBW
were higher than men 6.9 (5.9 to 7.9) vs. 6.6 (5.7 to 7.5)
ml kg1 ABW; median difference was 0.3 (0.2 to 0.4)
ml kg1 ABW (P< 0.001); and 8.6 (7.7 to 9.6) vs. 7.6 (6.8
to 8.4) ml kg1 PBW; median difference was 1.1 (1.0 to
1.1) ml kg1 PBW (P< 0.001). Women were less likely to
receive a default VT than men (64.3 vs. 67.9%; P< 0.001).
In the lower quintiles of height, VT,PBW was higher, an
effect that was stronger in women, and for every quintile
in ABW, women received a higher VT,PBW (Supplemen-
tary eFigs. 4 and 5, http://links.lww.com/EJA/A517).
Although women received a lower absolute VT, the
VT,PBW was always higher than in men (Supplementary
eFigs. 6 and 7, http://links.lww.com/EJA/A517). The
proportion of women receiving VT more than 9 ml kg
1
was three times higher than in men (39.3 vs. 13.8%;
P< 0.001); the proportion of females receiving VT
10 ml kg1 or higher was four times higher than in men
(18.8 vs. 4.3%; P< 0.001). Intra-operative driving pres-
sures were higher in women than in men, albeit that the
difference between sexes was small.
The proportion of women receiving intra-operative
LTVV was less than half of that in males (31.1 vs.
64.0%; P< 0.001). Women were at a higher risk of not
receiving intra-operative LTVV than men (68.8 vs.
36.0%; P< 0.001). After adjustment for confounders,
the difference in use of LTVV persisted [–5.78 (–8.12
to –3.45), P< 0.001] (Supplementary eFig. 8, http://
links.lww.com/EJA/A517). In the lowest quintiles of
height, and in all quintiles of ABW, women received
LTVV less often than men (Fig. 2).
In the mediation models, mostly height and to a lesser
extent ABW were the independent drivers of the effect of
sex on use of intra-operative LTVV (Table 2). Use of a
default VT during intra-operative ventilation was not a
driver of the sex difference in use of LTVV.
Discussion
The main findings of the current analysis of the LAS
VEGAS database are that women, compared with men,
received higher median VT, ABW and higher median
VT,PBW during intra-operative ventilation. Consequently,
women received LTVV much less often, a finding that
was more pronounced in shorter women. The sex differ-
ence in use of LTVV was mostly mediated by differences
in height and ABW, and not by sex or the use of a
default VT.
This study has several strengths. It used a large and robust
database of a worldwide study in patients receiving intra-nauthorized reproduction of this article is prohibited.
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Table 1 Baseline characteristics of the patients
Female (n U 5425) Male (n U 4439) P
Age (years) 52 [39 to 64] 55 [40 to 67] <0.001
Height (cm) 164 [159 to 168] 175 [170 to 180] <0.001
Weight (kg) 70 [60 to 81] 82 [72 to 93] <0.001
PBW (kg) 56.1 [51.5 to 59.7] 70.6 [66.0 to 75.1] <0.001
BMI (kg m2) 25.9 [22.7 to 30.4] 26.5 [24.1 to 29.7] <0.001
ASA physical status <0.001
1 1720 (31.8) 1293 (29.2)
2 2703 (50.0) 2040 (46.0)
3 907 (16.8) 996 (22.5)
4 75 (1.4) 98 (2.2)
5 4 (0.1) 4 (0.1)
ARISCAT score 15.00 [3.00 to 26.00] 16.00 [3.00 to 27.00] 0.293
Low 3806 (73.4) 2937 (69.4) <0.001
Moderate 1148 (22.2) 1067 (25.2)
High 228 (4.4) 227 (5.4)
Pre-operative anaemia (Hb 10 g dl1) 204 (4.5) 125 (3.4) 0.015
Pre-operative haemoglobin, g dl1 13.2 [12.2 to 14.0] 14.6 [13.3 to 15.5] <0.001
Pre-operative SpO2, % 98 [96 to 99] 97 [96 to 99] <0.001
Respiratory infection <30 days 198 (3.6) 165 (3.7) 0.902
Blood transfusion <30 days 43 (0.8) 32 (0.7) 0.771
Pre-operative creatinine (mmol l1) 64.6 [56.6 to 78.0] 80.5 [70.7 to 97.3] <0.001
Functional status 0.265
Independent 5027 (92.7) 4078 (92.0)
Partially dependent 331 (6.1) 290 (6.5)
Totally dependent 65 (1.2) 67 (1.5)
Chronic comorbidities
Smoking 1008 (18.6) 1282 (28.9) <0.001
Chronic obstructive pulmonary disease 263 (4.8) 333 (7.5) <0.001
Cancer 190 (3.5) 202 (4.6) 0.009
Chronic kidney disease 125 (2.3) 185 (4.2) <0.001
Heart failure 288 (5.3) 297 (6.7) 0.004
Obstructive sleep apnoea 91 (1.7) 114 (2.6) 0.003
Planned duration of surgery <0.001
2 h 3899 (72.0) 2963 (66.9)
2 to 3 h 1021 (18.9) 893 (20.1)
>3 h 495 (9.1) 576 (13.0)
Urgency of surgerya <0.001
Elective 4888 (90.1) 3877 (87.4)
Urgent 415 (7.7) 430 (9.7)
Emergency 121 (2.2) 131 (3.0)
Surgical techniqueb
Open 933 (17.2) 840 (18.9) 0.028
Laparoscopic 1167 (21.5) 570 (12.8) <0.001
Laparoscopic-assisted 97 (1.8) 70 (1.6) 0.465
Peripheral 964 (17.8) 863 (19.4) 0.036
Other type 2309 (42.6) 2118 (47.7) <0.001
Surgical procedure
Lower gastrointestinal 486 (9.0) 610 (13.7) <0.001
Upper gastrointestinal 774 (14.3) 583 (13.1) 0.110
Vascularc 103 (1.9) 206 (4.6) <0.001
Aortic 8 (0.1) 56 (1.3) <0.001
Neurosurgery, head and neck 962 (17.7) 1044 (23.5) <0.001
Urological and kidney 214 (3.9) 651 (14.7) <0.001
Gynaecological 1134 (20.9) 0 (0.0) <0.001
Endocrine 151 (2.8) 43 (1.0) <0.001
Transplant 12 (0.2) 22 (0.5) 0.032
Plastic, cutaneous, breast 784 (14.5) 253 (5.7) <0.001
Bone, joint, trauma spine 736 (13.6) 859 (19.4) <0.001
Others 246 (4.5) 339 (7.6) <0.001
Data are presented as median [IQR] or n (%). ARISCAT, Assess Respiratory Risk in Surgical Patients in Catalonia; ASA, American Society of Anesthesiologists; Hb,
haemoglobin; PBW, predicted body weight. a Urgency of surgery, elective: surgery that is scheduled in advance because it does not involve a medical emergency; urgent,
surgery required within<48 h; emergency, nonelective surgery performed when the patient’s life or wellbeing is in direct jeopardy. b Patient can have more than one.
c Vascular surgery is carotid endarterectomy, aortic surgery and peripheral vascular taken together.operative mechanical ventilation during general anaesthesia
for various types of surgery. The study had a multicentre
design, increasing the generalisability of the findings. VT,
ABW and VT,PBW could be calculated in all patients, and theight © European Society of Anaesthesiology. Un
Eur J Anaesthesiol 2021; 38:1–8amount of missing data was very small. The analysis fol-
lowed a strict analysis plan that used sophisticated statistical
computations and the mediation analysis allowed us to
explain the sex difference in use of LTVV.authorized reproduction of this article is prohibited.
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PBW calculated according to standard formula. P value from the unadjusted mixed-effect linear model with centres as random effect. ABW, actual
body weight; PBW, predicted body weight.This study is the largest investigation that shows differ-
ences in VT titrations between women and men under-
going invasive ventilation during general anaesthesia for
surgery. Its findings are in line with results from previous
single-centre10 and national investigations11,14–16 that all
showed women to be at risk of receiving larger VT,PBW
compared with men. Its findings also suggest that anaes-
thesiologists are titrating VT to ABW more than PBW,
and foregoing the cumbersome process of measuring
height and performing the PBW calculation altogether.yright © European Society of Anaesthesiology. U
PR




















































A low tidal volume was defined as a tidal volume 8 ml kg1. PBW calcula
predicted body weight.OF
Nevertheless, anaesthesiologists may have been inter-
ested in lung-protective ventilation, as the VT based on
ABW was less than 7 ml kg1 for both women and men.
Thus far, studies performed in the operating room10,11,14–
16 as well as studies performed in the ICU12 failed to
identify the factors behind sex differences in use of
LTVV. The current findings add to our knowledge by
showing that the sex difference in use of LTVV is mostly
driven by patients’ height and ABW. The latter findingnauthorized reproduction of this article is prohibited.
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Table 2 Mediation analysis
Adjusted absolute difference (95% CI)
a,b P
Low tidal volume ventilation
Height as mediatorc
Total effect of sex 32.91 (34.99 to 31.00) <0.001
Average causal mediation effect of height 26.56 (28.14 to 25.00) <0.001
Average direct effect of female sex 6.35 (8.67 to 4.00) <0.001
Proportion of mediation by height in female sex 80.70 (74.76 to 87.00) <0.001
Actual body weight as mediatord
Total effect of sex 5.41 (7.81 to 3.00) <0.001
Average causal mediation effect of weight 0.95 (0.42 to 2.00) <0.001
Average direct effect of female sex 6.37 (8.73 to 4.00) <0.001
Proportion of mediation by weight in female sex 17.65 (39.54 to 7.00) <0.001
Default VT as mediator
e
Total effect of sex 5.14 (7.55 to 3.00) <0.001
Average causal mediation effect of default VT 0.00 (0.05 to 0.00) 0.730
Average direct effect of female sex 5.13 (7.54 to 3.00) <0.001
Proportion of mediation by weight in female sex 0.05 (0.60 to 1.00) 0.730
Height, weight and default VT as mediators
f
Total effect of sex 30.80 (34.30 to 27.20) <0.001
Average causal mediation effect of height 31.90 (34.10 to 29.70) <0.001
Average causal mediation effect of weight 6.10 (5.00 to 7.20) <0.001
Average causal mediation effect of default VT 0.00 (0.10 to 0.10) 0.618
Average direct effect of female sex 5.00 (8.80 to 1.10) 0.011
ASA, American Society of Anesthesiologists’ physical status; ARISCAT, Assess Respiratory Risk in Surgical Patients in Catalonia for postoperative pulmonary
complications’ (ARISCAT) score; etCO2, end-tidal carbon dioxide tension.
a Multilevel mediation model with quasi–Bayesian confidence intervals, with centres as random
effects and adjusted for ASA, ARISCAT, presence of obstructive sleep apnoea, urgency of surgery, total fluid intake, need of intra-operative transfusion, reversal of
neuromuscular blockade, duration of anaesthesia and intra-operative etCO2.
b All estimates generated after 10 000 simulations. c Further adjusted by weight and default
VT.
d Further adjusted by height and default VT.
e Further adjusted by height and weight. f Adjusted only for the variables described in ‘a’ (height, weight and default VT
excluded) and confidence intervals estimated with bootstrapping with 1000 samples.PR
Osuggests that the risk of using too large a VT can also occurin men, that the risk is larger in shorter individuals andthat it also affects overweight patients. This is in line withprevious investigations showing that these anthropomet-ric indices influence the risk of receiving intra-operativeventilation with an incorrectly titrated VT.10,11,14–16,17
The current findings reject the hypothesis that incorrect
titration of VT is a sex-specific problem.
In settings with shorter individuals, the problem of
receiving ventilation with too large a VT could even be
greater, albeit that the average differences in height
between women and men is nearly 10–15 cm world-
wide.18,19 The same could be true in areas where there
are more overweight or obese individuals. However, the
current findings should increase the awareness of using
the correct information for proper VT titrations – patient’s
height, maybe patient’s sex but not patient’s ABW –
should be considered when titrating VT.
Our finding of sex disparity in VT titrations mirrors the
practice of ventilation in critically ill patients, for example
invasive ventilation in ICUs. Indeed, not only in unse-
lected critically ill patients,19–22 but also in specific ICU
cohorts such as organ donors,23 patients with sepsis24 and
even in patients with ARDS,25 women continue to
receive LTVV less often than males. These findings
suggest that the problem is widespread, and also needs
attention beyond the operating room. Furthermore, the
effect of anthropometric factors on intra-operative VT
titrations, and thus, the use of LTVV may be moreight © European Society of Anaesthesiology. Un
Eur J Anaesthesiol 2021; 38:1–8Oimportant in patients undergoing more extreme proce-
dures, for example intrathoracic procedures that require
one-lung ventilation. In these patients, use of lung-pro-
tective ventilation is reported to be low26 and every effort
to improve this may result in better postoperative out-
comes.
One additional finding was that patients undergoing
surgery frequently receive a default VT. This was also
found in one French study.11 Using a default VT could be
more straightforward and is probably an easier approach
at the bedside than collecting or measuring patients’
height, and performing a rather complex calculation.
Of note, the mediation analysis showed use of a default
VT did not mediate the effect of sex on use of LTVV. One
possible explanation is that a default VT may already have
been adjusted for sex, that is lower default VT may have
been use in women than in men. This could be a practical
alternative for use at the bedside, albeit that a default VT
could better be based on whether the patient is ‘short’ or
‘tall’, than whether the patients is female or male.27
The results of our study should be seen against a back-
ground of an ongoing uncertainty regarding what is the
best VT during intra-operative ventilation. Although mul-
tiple studies directly2,5,10 or indirectly28,29 suggest benefit
from a low VT, the results of one recent study
30 suggest
otherwise. In that study, intra-operative ventilation with a
VT of 6 ml kg
1 PBW was compared with a VT of
10 ml kg1 and resulted in a similar proportion of patients
who developed PPC. Additional studies are needed toauthorized reproduction of this article is prohibited.
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help decide what VT to use in intra-operative ventilation
during general anaesthesia for surgery.
Several limitations need to be mentioned. First, this was a
posthoc analysis. However, to prevent data-driven analysis
and reporting, we developed a cautious statistical model,
aiming to compensate for potential confounding factors.
Second, the present findings may not apply to all patient
categories, such as children, patients undergoing cardiac
surgery or one-lung ventilation during surgery, and preg-
nant women, as these patients were excluded from the
original LAS VEGAS study.9 Third, the LAS VEGAS
study was performed more than 7 years ago. It is possible
that changes in clinical practice over recent years resulted
in a further reduction in VT, mitigating sex differences in
use of LTVV. It should be mentioned, however, that the
sex differences found in the current analysis were not
different from those in an earlier study in which patients
received ventilation with a much higher VT.
10 Fourth,
patients’ height and ABW were collected from patients’
records, assuming that these were correctly reported – this
may not be true for all patients – however, it seems logical
that the recorded height was used to set VT. Fifth, addi-
tional confounders such as actual practice and personal
preferences of the anaesthesiologist could not be
accounted for in the mediation analysis. It is possible that
these and other yet unknown factors could have influenced
the findings. Sixth, we conducted a complete case analysis,
considering only patients for whom data needed for calcu-
lation of the outcome were available. Finally, we assumed
that every rounded VT was a default VT. Although we
cannot conclude that use of a default VT had no mediation
effect, we can state that use of a rounded VT did not
mediate the sex difference in use of LTVV.
Conclusion
During ventilation for general anaesthesia, women are
less likely to receive LTVV than men. This sex differ-
ence is mostly mediated by patients’ height and ABW.
These findings raise the awareness of the importance of
proper titration of VT in operating rooms.
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